Comera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery Conference

October 16, 2023

WOBURN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) — Comera Life Sciences Holdings, Inc. (Nasdaq:CMRA), a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today will present research demonstrating Comera’s SQore™ platform capabilities in the development of subcutaneous monoclonal antibody formulations at the PODD: Partnerships in Drug Delivery conference in Boston, Mass.

Related news for (CMRA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.

Comera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery Conference

Related news for (CMRA)

Follow Us on Social Media

Sign Up for Our Newsletter

Related news for (CMRA)

Kraig Labs Positioned at the Forefront of the Next-Gen Materials Revolution

Power Hour Pulse: Crypto Catalysts, SaaS Surges, and Speculation Swirls

Spider Silk, Silicon, and Surprises: Market Threads Weaving a Volatile Morning

TEN Holdings Powers Up with SaaS Pivot

Morning Market Editorial: Biotech, Bitcoin, and AI – Small-Caps Make Big Moves

Follow Us on Social Media

Sign Up for Our Newsletter